Alveus Therapeutics
PrivateLast Round
Series A
Extension
Feb 24, 2026
Total Funding Raised
$234M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Alveus Therapeutics is a biotechnology company developing next-generation therapies for obesity and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alveus Therapeutics Comparables
Compare Alveus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verdiva Bio | 86% | |
| Antag Therapeutics | 85% | |
| Pep2Tango Therapeutics Inc. | 85% | |
Alveus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Feb 24, 2026 | ||||
| Series A | Jan 8, 2026 |
Alveus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Avego Management | Series A, Series A Extension |
| Omega Funds | Series A, Series A Extension |
| Andera Partners | Series A, Series A Extension |
| New Rhein Healthcare Investors | Series A, Series A Extension |
| Novo Holdings | Series A Extension |
| Sanofi Ventures | Series A Extension |
| Jeito Capital | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 40% MoM.
- Jun 4, 2026
Grew 22% QoQ, from 27 to 33 employees.
Alveus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Alveus Therapeutics's valuation, stock price, and market status.